Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages

Author： Llaveras G. Jove M. Vazquez-Carrera M. Sanchez R.M. Daz C. Hernandez G. Laguna J.C. Alegret M.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.451, Iss.1, 2002-09, pp. : 11-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesteryl ester transfer protein inhibitors

By Shinkai H.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

By Kappelle Paul JWH Zwang Louwerens Huisman Menno V Banga Jan Dirk Sluiter Wim J Dallinga-Thie Geesje M Dullaart Robin PF

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 743-751

Informa Healthcare

Access to resources Recommend Favorite

Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages

By Rocher Crystal Singla Reetu Singal Pawan K. Parthasarathy Sampath Singla Dinender K.

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 7, 2012-07 ,pp. : 947-951

NRC Research Press

Access to resources Recommend Favorite

Dalcetrapib, a cholesteryl ester transfer protein modulator

By Hooper Amanda J Burnett John R

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1427-1432

Informa Healthcare

Access to resources Recommend Favorite

Anacetrapib, a cholesteryl ester transfer protein inhibitor

By Hooper Amanda J Burnett John R

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite